Skip to Main Content

Paper Details

Heterozygous pathogenic variants in POMC are not responsible for monogenic obesity: Implication for MC4R agonist use.
0
2023
Human, MC4R, POMC, POMC variant, POMC variants, Recessive deficiency of proopiomelanocortin, childhood, childhood-onset obesity, melanocortin 4 receptor, monogenic obesity, obesity, patients
Author NameAffiliation
Philippe FroguelInserm/CNRS UMR 3/8199, Pasteur Institute of Lille, France University of Lille, Imperial College London
Amélie BonnefondInserm/CNRS UMR 3/8199, Pasteur Institute of Lille, France University of Lille, Imperial College London
  • 1 - 2

Datasets

Release 1.2